Skip to Main content Skip to Navigation
New interface
Journal articles

Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0

Abstract : Familial platelet disorder with predisposition to acute myeloid leukaemia (FPD/AML) is characterized by germline RUNX1 mutations, thrombocy-topaenia, platelet dysfunction and a risk of developing acute myeloid and in rare cases lymphoid T leukaemia. Here, we focus on a case of a man with a familial history of RUNX1 R174Q mutation who developed at the age of 42 years a T2-ALL and, 2 years after remission, an AML-M0. Both AML-M0 and T2-ALL blast populations demonstrated a loss of 1p36.32-23 and 17q11.2 regions as well as other small deletions, clonal rearrangements of both TCRc and TCRd and a presence of 18 variants at a frequency of more than 40%. Additional variants were identified only in T2-ALL or in AML-M0 evoking the existence of a common original clone, which gave rise to subclonal populations. Next generation sequen-cing (NGS) performed on peripheral blood-derived CD34 + cells 5 years prior to T2-ALL development revealed only the missense TET2 P1962T mutation at a frequency of 1%, which increases to more than 40% in fully transformed leukaemic T2-ALL and AML-M0 clones. This result suggests that TET2 P1962T mutation in association with germline RUNX1 R174Q mutation leads to amplification of a haematopoietic clone susceptible to acquire other transforming alterations.
Complete list of metadata

Cited literature [7 references]  Display  Hide  Download

https://hal.sorbonne-universite.fr/hal-01537098
Contributor : Gestionnaire 2 HAL-UPMC Connect in order to contact the contributor
Submitted on : Monday, June 12, 2017 - 12:19:03 PM
Last modification on : Monday, November 28, 2022 - 10:38:07 AM

File

Manchev_et_al-2017-Journal_of_...
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Vladimir T. Manchev, Hind Bouzid, Iléana Antony-Debré, Betty Leite, Guillaume Meurice, et al.. Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0. Journal of Cellular and Molecular Medicine, 2017, 21 (6), pp.1237 - 1242. ⟨10.1111/jcmm.13051⟩. ⟨hal-01537098⟩

Share

Metrics

Record views

258

Files downloads

195